| Authors: |
Elghawy O; Lymphoma Program, Abramson Cancer Center, Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Yang AG; Lymphoma Program, Abramson Cancer Center, Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Sussman JH; Lymphoma Program, Abramson Cancer Center, Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Thomas CJ; Lymphoma Program, Abramson Cancer Center, Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Carter JS; Lymphoma Program, Abramson Cancer Center, Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Landsburg DJ; Lymphoma Program, Abramson Cancer Center, Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Svoboda J; Lymphoma Program, Abramson Cancer Center, Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Kim E; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Rook AH; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Chung J; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Villasenor-Park J; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania., Plastaras JP; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., LaRiviere M; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Hubbeling H; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Chelius M; Department of Radiation Oncology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania., Nasta SD; Lymphoma Program, Abramson Cancer Center, Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Chong EA; Lymphoma Program, Abramson Cancer Center, Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Schuster SJ; Lymphoma Program, Abramson Cancer Center, Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania., Barta SK; Lymphoma Program, Abramson Cancer Center, Division of Hematology and Oncology, University of Pennsylvania, Philadelphia, Pennsylvania. Electronic address: stefan.barta@pennmedicine.upenn.edu. |